79 related articles for article (PubMed ID: 23467686)
21. Overcome of Cisplatin Resistance in Ovarian Cancer by Combination of Low-intensity Ultrasound and Cisplatin.
Kip B; Aydin O
Curr Drug Deliv; 2023; 20(9):1380-1390. PubMed ID: 35761504
[TBL] [Abstract][Full Text] [Related]
22. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
[TBL] [Abstract][Full Text] [Related]
23. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA
Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108
[TBL] [Abstract][Full Text] [Related]
24. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
Li J; Jiang K; Zhao F
Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
Hamad SA; Beale P; Yu JQ; Huq F
Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
[TBL] [Abstract][Full Text] [Related]
26. [Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol].
Shi XY; Cai XJ; Lei JX; Cao FJ; Pan DF; Chen P
Ai Zheng; 2008 Apr; 27(4):343-7. PubMed ID: 18423117
[TBL] [Abstract][Full Text] [Related]
27. Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.
Zhang B; Wang X; Cai F; Chen W; Loesch U; Zhong XY
Oncol Rep; 2013 Apr; 29(4):1371-8. PubMed ID: 23338561
[TBL] [Abstract][Full Text] [Related]
28. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
[TBL] [Abstract][Full Text] [Related]
30. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
Wang Y; Niu XL; Qu Y; Wu J; Zhu YQ; Sun WJ; Li LZ
Cancer Lett; 2010 Sep; 295(1):110-23. PubMed ID: 20236757
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
[TBL] [Abstract][Full Text] [Related]
32. Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.
Roberts D; Schick J; Conway S; Biade S; Laub PB; Stevenson JP; Hamilton TC; O'Dwyer PJ; Johnson SW
Br J Cancer; 2005 Mar; 92(6):1149-58. PubMed ID: 15726096
[TBL] [Abstract][Full Text] [Related]
33. Effect of extracellular ATP on cisplatin-induced cytotoxicity in human ovarian carcinoma cells.
Rotte A; Garmann D; Buss I; Jaehde U
Chemotherapy; 2010; 56(1):1-8. PubMed ID: 20185910
[TBL] [Abstract][Full Text] [Related]
34. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
[TBL] [Abstract][Full Text] [Related]
35. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.
Appierto V; Villani MG; Cavadini E; Lotan R; Vinson C; Formelli F
Cell Death Differ; 2004 Mar; 11(3):270-9. PubMed ID: 14647238
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of coiled coil domain containing protein 69 enhances platinum-induced apoptosis in ovarian cancer cells.
Cui L; Liang B; Yang Y; Zhu M; Kwong J; Zheng H; Wang CC
Oncotarget; 2017 Nov; 8(60):101634-101648. PubMed ID: 29254192
[TBL] [Abstract][Full Text] [Related]
37. Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models.
Arzuman L; Beale P; Yu JQ; Huq F
Anticancer Res; 2015 May; 35(5):2783-94. PubMed ID: 25964558
[TBL] [Abstract][Full Text] [Related]
38. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
39. MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88.
Zhan Y; Xiang F; Wu R; Xu J; Ni Z; Jiang J; Kang X
J Ovarian Res; 2015 Jul; 8():48. PubMed ID: 26223974
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]